Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product
Accuray Incorporated (ARAY)
Last accuray incorporated earnings: 4/28 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.accuray.com/investor-overview
Company Research
Source: PR Newswire
MADISON, Wis., Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo® C Radiation Treatment Delivery System, a product built in China through the CNNC-Accuray joint venture. Shandong Cancer Hospital and Institute was the first hospital in China to receive the new Tomo C System which has already demonstrated its value by expanding clinical capabilities and the opportunity to offer potentially curative treatment to more people diagnosed with cancer. This first cohort of Tomo C System treatments also represent a milestone for Accuray which is focused on addressing the broad needs of the underserved Chinese radiation therapy market.The number of new cancer cases in China is anticipated to increase by almost 47 percent in the coming years with about 7.1 million people expected to be diagnosed in 2045, compared to an estimated 4.8
Show less
Read more
Impact Snapshot
Event Time:
ARAY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARAY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARAY alerts
High impacting Accuray Incorporated news events
Weekly update
A roundup of the hottest topics
ARAY
News
- Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth [YahYah
- Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growthPR Newswire
- Accuray Incorporated (NASDAQ:ARAY) is largely controlled by institutional shareholders who own 59% of the company [Yahoo! Finance]Yahoo! Finance
- Accuray (NASDAQ:ARAY) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Accuray (NASDAQ:ARAY) had its price target lowered by analysts at BTIG Research from $5.00 to $4.00. They now have a "buy" rating on the stock.MarketBeat
ARAY
Earnings
- 8/13/25 - Miss
ARAY
Analyst Actions
- 11/6/25 - BTIG
ARAY
Sec Filings
- 12/16/25 - Form 8-K
- 12/2/25 - Form 4
- 12/2/25 - Form 4
- ARAY's page on the SEC website